The AMC Theater is photographed amid the coronavirus disease (COVID-19) pandemic in the Manhattan borough of New York City, New York, United States, January 27, 2021.
Carlo Allegri | Reuters
Check out which companies are making the headlines in midday trading.
bed bath behindAnd the AMC – Shares are up 41% and 13% respectively with the advent of social media traders Invest in two meme shareseven without an apparent catalyst.
sign of health – The stock jumped 13% after a The Wall Street Journal reportCiting people familiar with the matter, CVS Health plans to make an offer to the home health services company.
First Solar – First Solar jumps 5% after Goldman Sachs Stock upgrade to gain weight from neutral. The bank said solar technology stocks should benefit from the passage of the Inflation Reduction Act and raise the target price to $126 from $83 per share.
rhythm for pharmaceutical industries Biopharma stock rose 7% after Goldman Sachs Upgrade it to buy from Neutralsaying that stocks could rise by about 40% after successful trials of obesity medicine.
Barrick Gold The mine jumped 5% after beating analyst expectations for its second-quarter results, due to higher copper production.
Palantir . techniques Palantir shares fell more than 13% after the software company known for its work with the government reported a 1 percent loss in its stake in its most recent quarter. Analysts had been expecting earnings of 3 cents per share, according to Refinitiv. Chief Financial Officer David Glazer told CNBC that the company’s failure was due to a decline in investments and marketable securities.
Tyson Foods – Shares of the food products company fell 8% after Tyson missed earnings estimates in the third quarter of the fiscal year. Company executives said on a phone call with investors that supply chain issues were hurting its ability to meet customer demands, according to a transcript of the call from FactSet.
nvidia Semiconductor inventory fell more than 8% after Nvidia reported a loss of revenue in its second-quarter results. The chip maker generated $6.7 billion in revenue, compared to analysts’ expectations of $8.1 billion, due to weak gaming.
Biotechnology – The German biotech company, which partnered with Pfizer on the Covid-19 vaccine, fell 9% after reporting earnings and revenue that beat expectations. The company said its adaptive Covid-19 vaccine should provide increased demand in the fourth quarter.
– CNBC’s Tanaya Machel, Jesse Pound, Samantha Sobin and CNBC’s Michelle Fox Theobald contributed to this report.
“Beer fan. Travel specialist. Amateur alcohol scholar. Bacon trailblazer. Music fanatic.”